惊厥性癫痫持续状态后临床医生报告的身体和认知损害:一项随机对照试验的事后研究
本研究为HYBERNATUS试验的事后分析,该多中心开放标签对照试验在11个法国ICU将270例需机械通气的CSE患者随机分配至治疗性低温(32-34°C持续24小时)加标准治疗或单纯标准治疗。229例第90天GOS≥3的患者中,67例(29%)参加了面对面神经科随访,并测量FIM、MMSE和GOS评分。第90天中位FIM为121(112-125),中位MMSE为26.0(24.0-28.8);GOS评分越差,FIM和MMSE评分越差,具有显著关联。作者认为主要损害为认知损害,需进一步研究神经保护和康复策略对CSE幸存者残疾和认知损害的可能影响。
要点
- HYBERNATUS试验纳入270例需机械通气的CSE患者,随机接受治疗性低温(32-34°C持续24小时)加标准治疗或单纯标准治疗。
- 229例第90天GOS≥3的患者中仅67例(29%)参加面对面神经科随访,其中43%有癫痫病史,33%为难治性CSE。
- 第90天中位FIM为121(112-125)、中位MMSE为26.0(24.0-28.8),提示主要损害为认知损害。
- GOS评分越差与FIM和MMSE评分越差显著相关,GOS 3分16例(33.8%)、4分9例(13.4%)、5分42例(62.7%)。
- 作者认为需进一步研究神经保护和康复策略对CSE幸存者残疾和认知损害的可能影响。
适用人群与场景
- HYBERNATUS试验纳入的需机械通气并入住ICU的惊厥性癫痫持续状态(CSE)成人患者,来自11个法国ICU。
- 本事后分析纳入第90天GOS评分≥3且参加面对面神经科随访并完成FIM、MMSE、GOS评估的患者,共67例。
诊断标准与关键阈值
- GOS评分:1分为死亡,2分为植物状态,3分为严重残疾,4分为中度残疾,5分为轻度或无残疾。
- FIM评分范围18分(完全依赖)至126分(完全独立)。
- MMSE评分范围0-30分。
研究设计与关键结果
- 研究类型:HYBERNATUS多中心开放标签随机对照试验的事后分析;11个法国ICU;270例需机械通气的CSE患者随机分配至治疗性低温(32-34°C持续24小时)加标准治疗或单纯标准治疗。
- 229例第90天GOS≥3的患者中,67例(29%)参加面对面神经科随访;男性58.2%,中位年龄56岁(47-67)。
- 67例中29例(43%)有癫痫病史,16例(24%)有原发性脑损伤,22例(33%)CSE为难治性。
- 第90天中位FIM为121(112-125),中位MMSE为26.0(24.0-28.8)。
- 第90天GOS评分3分16例(33.8%)、4分9例(13.4%)、5分42例(62.7%)。
- GOS评分越差与FIM和MMSE评分越差显著相关。
证据类型、等级与局限
- 证据类型:随机对照试验(HYBERNATUS,NCT01359332)的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,CSE后90天接受面对面神经科随访的患者中,临床医生报告的主要损害为认知损害,FIM和MMSE评分与GOS评分相关。
- 作者认为,需进一步研究评估神经保护和康复策略对CSE幸存者残疾和认知损害的可能影响。
指南或共识出处
- HYBERNATUS试验(NCT01359332)事后分析,发表于Neurocrit Care。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Clinician-reported outcome (ClinRO) measures are emerging as useful contributors to assessments of treatment benefits. The objective of this study was to collect ClinRO measures of physical and cognitive impairments after convulsive status epilepticus (CSE) requiring intensive care unit admission.
METHODS: We conducted a post hoc analysis of the data from HYBERNATUS, a multicenter open-label controlled trial that randomized 270 critically ill patients with CSE requiring mechanical ventilation in 11 French intensive care units to therapeutic hypothermia (32-34 °C for 24 h) plus standard care or standard care alone. We included all patients who attended a day 90 in-person neurologist visit with measurement of the functional independence measure (FIM) score (range from 18 [total assistance] to 126 [total independence]), Mini-Mental State Examination (MMSE) score (range 0-30), and Glasgow outcome scale (GOS) score (1, death; 2, vegetative state; 3, severe disability; 4, moderate disability; and 5, mild or no disability). These three scores were compared across groups defined by several patient and CSE characteristics.
RESULTS: Of 229 patients with GOS scores ≥ 3 on day 90 (male sex, 58.2%; median age, 56 years [47-67]), 67 (29%) attended an in-person neurologist visit. Twenty-nine (43%) patients had a previous history of epilepsy, and 16 (24%) patients had a primary brain insult. CSE was refractory in 22 (33%) patients. On day 90 after CSE onset, median FIM and MMSE scores were 121 (112-125) and 26.0 (24.0-28.8), respectively. The GOS score was 3 in 16 (33.8%) patients, 4 in 9 (13.4%) patients, and 5 in 42 (62.7%) patients. Worse GOS score values were significantly associated with worse FIM and MMSE scores.
CONCLUSIONS: In patients attending the in-person neurologist visit on day 90 after CSE onset, ClinRO measures indicated that the main impairments were cognitive. FIM and MMSE scores were associated with GOS scores. Further studies are needed to evaluate the possible impact of neuroprotective and rehabilitation strategies on disability and cognitive impairments in survivors of CSE. Clinical trial registration NCT01359332.
参考来源
- Jacq G, Crepon B, Resche-Rigon M, et al. Clinician-Reported Physical and Cognitive Impairments After Convulsive Status Epilepticus: Post Hoc Study of a Randomized Controlled Trial. Neurocrit Care. 2023. PMID: 37286846. doi:10.1007/s12028-023-01758-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。